The first participants received shots in a 30,000-person trial of an experimental vaccine being developed by biotech company Moderna in partnership with the U.S. government.
SOURCE: The Washington Post
The first participants received shots in a 30,000-person trial of an experimental vaccine being developed by biotech company Moderna in partnership with the U.S. government.
SOURCE: The Washington Post
